A Canadian Press piece appearing in several newspapers and broadcast news reports features closely-held Scientus Pharma and other companies as they look beyond legalization of recreational cannabis this summer to developing cannabis-based pharmaceuticals.
The potential down the road is far greater than the recreational market size, says Har Grover, Scientus’ CEO, in the CP piece. “What you need to do is deliver medicine in a form that patients and physicians are used to using,” he added.
